Page last updated: 2024-09-03

rx-ra 69 and Lung Neoplasms

rx-ra 69 has been researched along with Lung Neoplasms in 2 studies

*Lung Neoplasms: Tumors or cancer of the LUNG. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haarmann, W; Lichtner, R1
Hellmann, K; Hutchinson, G; Lichtner, RB; Wedderburn, N1

Reviews

1 review(s) available for rx-ra 69 and Lung Neoplasms

ArticleYear
Antiplatelet pyrimido-pyrimidines and metastasis.
    Cancer treatment reviews, 1985, Volume: 12, Issue:4

    Topics: Animals; Blood Platelets; Cyclic AMP; Humans; Lung Neoplasms; Melanoma; Mice; Mopidamol; Neoplasm Metastasis; Platelet Aggregation; Pyrimidines; Rats

1985

Other Studies

1 other study(ies) available for rx-ra 69 and Lung Neoplasms

ArticleYear
Antimetastatic action of RX-RA 69, a new potent PDE-inhibitor in the Lewis lung carcinoma of the mouse.
    Progress in clinical and biological research, 1982, Volume: 89

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Aggregation; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Platelet Aggregation; Pyrimidines

1982